These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5889)

  • 1. Residues in antibiotic preparations, ii: effect of pH on the nature and level of particulate matter in sodium cephalothin intravenous solutions.
    Rebagay T; DeLuca P
    Am J Hosp Pharm; 1976 May; 33(5):443-8. PubMed ID: 5889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residues in antibiotic preparations, i: scanning electron microscopic studies of surface topography.
    Rebagay T; Rapp R; Bivins B; DeLuca PP
    Am J Hosp Pharm; 1976 May; 33(5):433-43. PubMed ID: 5888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particulate evaluation of parenteral nutrition solutions by electronic particle counting and scanning electron microscopy.
    Akers MJ; Schrank GD; Russell S
    Am J Hosp Pharm; 1981 Sep; 38(9):1304-7. PubMed ID: 6792911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particulate matter in four reconstituted cephalosporin injections.
    Kilarski DJ; Visconti JA; Frank SG
    Am J Hosp Pharm; 1983 Apr; 40(4):619-23. PubMed ID: 6846372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of particles in intravenous fluids using scanning electron microscopy.
    Levinson RS; Allen LV; Stanaszek WF; Mills S
    Am J Hosp Pharm; 1975 Nov; 32(11):1137-41. PubMed ID: 1190235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Method for determination and element analysis of particulate contamination in injectable solutions.
    Winding O; Holma B
    Am J Hosp Pharm; 1976 Nov; 33(11):1154-9. PubMed ID: 998621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In line final filters for removing particles from amphotericin B infusions.
    Huber RC; Riffkin C
    Am J Hosp Pharm; 1975 Feb; 32(2):173-6. PubMed ID: 237416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Particulate contamination of infusion solutions and drug additives within the scope of long-term intensive therapy. 1. Energy dispersion electron images in the scanning electron microscope-REM/EDX].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Anaesthesist; 1989 Oct; 38(10):544-8. PubMed ID: 2511778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential hazard of particulate contamination of cardioplegic solutions.
    Robinson LA; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1984 Jan; 87(1):48-58. PubMed ID: 6690859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A strategy for reducing particulate contamination on opening glass ampoules and development of evaluation methods for its application.
    Lee KR; Chae YJ; Cho SE; Chung SJ
    Drug Dev Ind Pharm; 2011 Dec; 37(12):1394-401. PubMed ID: 21702739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of parenteral solutions of sodium cephalothin, cephaloridine, potassium penicillin G (buffered) and vancomycin hydrochloride.
    Mann JM; Coleman DL; Boylan JC
    Am J Hosp Pharm; 1971 Oct; 28(10):760-3. PubMed ID: 5125170
    [No Abstract]   [Full Text] [Related]  

  • 12. Particulate contamination and stability of three additives in 0.9% sodium chloride injection in plastic and glass large-volume containers.
    Stokes TF; Sumner ED; Needham TE
    Am J Hosp Pharm; 1975 Aug; 32(8):821-6. PubMed ID: 1146840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle contamination in a ternary nutritional admixture.
    Foroni LA; Rochat MH; Trouiller P; Calop JY
    J Parenter Sci Technol; 1993; 47(6):311-4. PubMed ID: 8120737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Particulate contamination of infusion solutions and drug additives in the framework of long-term intensive therapy. 2. An animal model].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Anaesthesist; 1989 Nov; 38(11):617-21. PubMed ID: 2635837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly supersaturated solutions from dissolution of amorphous itraconazole microparticles at pH 6.8.
    Matteucci ME; Paguio JC; Miller MA; Williams RO; Johnston KP
    Mol Pharm; 2009; 6(2):375-85. PubMed ID: 19236040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of intravenous admixtures of aztreonam and ampicillin.
    James MJ; Riley CM
    Am J Hosp Pharm; 1985 May; 42(5):1095-100. PubMed ID: 4039889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of particulate matter in intravenous solutions using the Coulter counter.
    Blaug SM; Sarabia RE
    Bull Parenter Drug Assoc; 1975; 29(2):74-88. PubMed ID: 1120215
    [No Abstract]   [Full Text] [Related]  

  • 18. Particulate matter content of D5/NS for injection.
    J Parenter Sci Technol; 1989; 43(2):53-5. PubMed ID: 2633761
    [No Abstract]   [Full Text] [Related]  

  • 19. Particulate contamination from siliconized rubber stoppers--a statistical evaluation.
    Li LC; Parasrampuria J; Tian Y
    J Parenter Sci Technol; 1993; 47(5):270-3. PubMed ID: 8263665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallization of three phenytoin preparations in intravenous solutions.
    Giacona N; Bauman JL; Siepler JK
    Am J Hosp Pharm; 1982 Apr; 39(4):630-4. PubMed ID: 7081239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.